It was almost as if someone decided April would be hepatitis C month.
In case you hadn’t notice, April saw publication of six separate articles in the New England Journal of Medicine on what were...
LONDON – Cure rates of 93%-100% were achieved in patients with chronic hepatitis C virus genotype 1 treated with both simeprevir and sofosbuvir despite the presence of advanced cirrhosis in a phase...
LONDON – Herbal medicines and other home remedies or supplements are a significant cause of hepatotoxicity experts warned recently during a symposium at the International Liver Congress, which...
Alterations in taste and smell, including aversions to many foods, are common following gastric bypass surgery, according to a report published online in Obesity Surgery.
Most of the literature...
Alterations in taste and smell, including aversions to many foods, are common following gastric bypass surgery, according to a report published online in Obesity Surgery.
Most of the literature...
BOSTON – The Centers for Medicare & Medicaid Services may have dropped its accreditation requirement for bariatric surgery centers, but that hasn’t stopped the flow of data calling into question...
LONDON – More than 90% of patients with chronic hepatitis C and compensated cirrhosis treated with a triple-acting, all-oral, direct-acting antiviral (DAA) regimen achieved sustained virologic...
LONDON – Simvastatin improves short-term survival after variceal bleeding in patients with cirrhosis, results of a phase III, randomized, double blind study have shown.
At 2 years’ follow-up in the...
BOSTON – The risks of readmission and emergency surgery are low for patients with acute diverticulitis initially managed nonoperatively, a population-based, competing risk analysis found.
At a...
LONDON – A single daily pill containing two novel antiviral agents produced sustained virologic response rates of more than 90% in as little as 8-12 weeks in three multicenter, open-label phase III...